Omiya, Japan

Mitsuru Segawa


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1995-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mitsuru Segawa: Innovator in Imidazole Derivatives

Introduction

Mitsuru Segawa is a notable inventor based in Omiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of imidazole derivatives. With a total of 3 patents to his name, Segawa's work has implications for selective antagonistic substances against muscarinic acetylcholine.

Latest Patents

One of Segawa's latest patents focuses on imidazole derivatives and the process for preparing them. This invention relates to imidazole derivatives represented by specific general formulas, which include various substituents that enhance their effectiveness as selective antagonists. The detailed chemical structure includes components such as phenyl groups, cyano groups, and lower alkyl groups, showcasing the complexity and innovation behind his work.

Career Highlights

Mitsuru Segawa is currently employed at Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His expertise in imidazole derivatives has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Segawa has collaborated with notable coworkers, including Hiroyuki Miyachi and Kei Okazaki. These partnerships have likely contributed to the success of his research and the advancement of their collective work in the pharmaceutical industry.

Conclusion

Mitsuru Segawa's contributions to the field of pharmaceuticals, particularly through his patents on imidazole derivatives, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…